In a major breakthrough that could reshape how neurological diseases are studied and treated, scientists have successfully programmed a wide range of human neurons in the lab using stem cells and finely tuned molecular signals. These lab-grown neurons closely mimic the structure, function, and activity of those found in the human brain and spinal cord.
This development offers new promise for conditions such as Alzheimer’s disease, Parkinson’s disease, and spinal injuries, where the loss or malfunction of specific neurons plays a central role. By generating these neurons in controlled laboratory settings, researchers hope to better understand how various types of neurons develop and function, and eventually how to replace or repair them.
The study, published in Science, involved profiling nearly 700,000 individual cells produced under 480 different experimental conditions. Using a combination of pioneering transcription factors and signalling molecules known as morphogens, researchers were able to create neurons that correspond to many different regions of the nervous system, including the forebrain, spinal cord, and peripheral nerves.
These lab-grown neurons were not just structurally different; they also behaved differently. Each subtype displayed distinct electrical activity, showing how subtle molecular variations in the lab setup could lead to dramatically different functional outcomes. This means scientists can now predictably generate neurons that not only look like their real-world counterparts but also act like them, opening new doors for testing treatments on neuron types previously difficult to access.
A central part of the breakthrough was the use of single-cell RNA sequencing, a technique that reads the gene expression profiles of individual cells. This allowed the team to map how combinations of morphogens and transcription factors guide stem cells into specific neural fates. The researchers also confirmed the key role of certain genes in this process by switching them on or off and observing the resulting changes.
Importantly, they found that the timing of when cells are exposed to these signals is crucial. Cells pre-patterned into neural progenitors before being exposed to transcription factors ended up producing more uniform and realistic neuron types than when the same factors were applied first. These neurons more closely resembled real human neurons, although they were slightly less mature.
While much work remains before these methods can be used in therapies, the implications for neuroscience are significant. Customised neuron cultures could accelerate drug discovery, reduce the need for animal testing, and one day help restore lost brain function through cell therapy. The findings also offer insights into how the nervous system develops and why some neurons are more vulnerable to disease.
This research marks one of the most comprehensive efforts to engineer human neuron diversity in a dish and lays the groundwork for future advances in regenerative medicine and brain modelling.